<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03850275</url>
  </required_header>
  <id_info>
    <org_study_id>16-05</org_study_id>
    <nct_id>NCT03850275</nct_id>
  </id_info>
  <brief_title>The Effects of e+Shots Energy Beverage on Mental Energy</brief_title>
  <official_title>The Effects of E+Shots Energy Beverage on Mood, Cognitive Function, Heart Rate, Blood Pressure, Cortisol and Fine Motor Task Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clarkson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Isagenix International LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Clarkson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the research project is to determine the changes in motivation to perform mental
      and physical tasks, feelings of vigor and fatigue, mental task vigilance and fine motor
      function after consumption of a commercially available energy product. The purpose of this
      study is determine whether e+shot, a product containing natural caffeine, will impact mood
      and performance up to 180 minutes post consumption compared to a sweetened solution
      containing synthetic caffeine.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 26, 2015</start_date>
  <completion_date type="Actual">December 15, 2016</completion_date>
  <primary_completion_date type="Actual">December 15, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double-blinded placebo controlled</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in POMS Energy</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>POMS Energy, Scores range from 0-20 with higher scores indicating improved outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in POMS Fatigue</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>POMS Fatigue Scores range from 0-20with higher scores indicating worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in POMS Depression</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>POMS Depression Scores range from 0-20 with higher scores indicating worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in POMS Anxiety</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>POMS Anxiety Scores range from 0-20 with higher scores indicating worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in POMS Anger</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>POMS Anger Scores range from 0-20 with higher scores indicating worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in POMS Confusion</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>POMS Anger Scores range from -4 to 16 with higher scores indicating worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serial Subtraction 3 Task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Serial subtraction 3- Number of attempts</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serial Subtraction 3 Task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Serial subtraction 3- Number correct</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serial Subtraction 3 Task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Serial subtraction 3- Percentage correct</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serial Subtraction 7 Task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Serial subtraction 7- Number of attempts</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serial Subtraction 7 Task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Serial subtraction 7- Number correct</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serial Subtraction 7 Task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Serial subtraction 7- Percentage correct</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Blood pressure- systolic and diastolic measured in mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in heart rate</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Heart rate- beats per minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in fine motor task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>9-hole peg test- measured in seconds</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in cortisol</measure>
    <time_frame>0 and 180 minutes</time_frame>
    <description>Cortisol measured in nano moles</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in state mental energy</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>State Mental Energy- scores range from 0 to 300 with higher scores indicating better outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in state physical energy</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>State Physical Energy- scores range from 0 to 300 with higher scores indicating better outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in state mental fatigue</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>State mental fatigue- scores range from 0 to 300 with higher scores indicating worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in state physical fatigue</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>State physical fatigue- scores range from 0 to 300 with higher scores indicating worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in continuous performance task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Continuous Performance Task- Percentage of correct responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in continuous performance task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Continuous Performance Task- Number of incorrect responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in continuous performance task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Continuous Performance Task- Percentage of missed responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in continuous performance task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Continuous Performance Task- reaction time for correct responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Primary task- percentage correct</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Primary task- percentage missed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Primary task- incorrect responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Primary task- reaction time for percent correct</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Secondary task- percentage correct</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Secondary task- percentage missed responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Secondary task- incorrect responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Secondary task- reaction time for correct responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Tertiary task- percentage correct responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Tertiary task- percentage missed responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Tertiary task- number of incorrect responses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in rapid visual input processing task performance</measure>
    <time_frame>30, 90, 120, 150 minutes</time_frame>
    <description>Rapid Visual Input Processing task- Tertiary task- reaction time for correct responses</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Caffeine</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>&lt;3mg of caffeine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caffeinated placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>~100mg caffeine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>E+shots</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>~100mg caffeine + adaptogens</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>E+shots</intervention_name>
    <description>The 4oz adaptogen-rich (E+shots) was E+ Shots (Isagenix International, LLC) containing approximately 90mg caffeine from green tea Camellia sinesis leaf extract (50%) and yerba maté extract (25%) along with a proprietary blend of adaptogenic herbs, including: eleutherococcus senticosus, crateagus oxycantha, rhodiola rosea and Schisandra chinensis.</description>
    <arm_group_label>E+shots</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Caffeinated placebo</intervention_name>
    <description>~100mg of synthetic caffeine</description>
    <arm_group_label>Caffeinated placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>~3mg caffeine</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18-45

          -  Body Mass Index (BMI) &lt; 30

          -  Profile of Mood Status Short Scale (POMS) score &lt;13 on the energy scale

          -  Energy and Fatigue trait scale score &lt;=10

          -  Consumption of &lt;200mg of caffeine/day

          -  Consumption of &lt;150 servings of polyphenols/month

        Exclusion Criteria:

          -  Subjects taking prescription or over the counter medications (except for oral
             contraceptives) for a chronic medical condition or recreational drugs will be excluded
             Chronic medical conditions are any health condition that is expected to last more than
             3 months and requires on going medical care such as coronary artery disease, multiple
             sclerosis, etc..

          -  Women who are pregnant or may be trying to become pregnant

          -  Women who are breastfeeding

          -  People who have been diagnosed with heart conditions and/or hypertension

          -  People who have liver disorders

          -  People who have sensitivity or allergy to caffeine

          -  People who have bipolar disorder

          -  People who have iron deficiency

          -  People who are allergic to plants of the Asteraceae/Compositae/Daisy family

          -  Day of testing

               -  Subjects who have had a change of ±2 hours of sleep from their regular sleep time
                  will be re-scheduled.

               -  If subjects begin taking a prescription or over the counter medication for an
                  acute condition (i.e. required to take the prescription or over the counter
                  medication for &lt; 3 months) during the study they will be given the option of
                  continuing the study after they are no longer taking the prescription or over the
                  counter medication or dropping out of the study.

               -  If subjects are diagnosed with a chronic condition that requires the use of
                  prescription medications for &gt; 3 months after they have started the study they
                  will be eliminated from the study.

               -  Resting systolic BP &gt; 180mmHg and diastolic BP &gt; 90mmHg after consuming the
                  caffeine beverage.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>July 18, 2018</study_first_submitted>
  <study_first_submitted_qc>February 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <last_update_submitted>February 20, 2019</last_update_submitted>
  <last_update_submitted_qc>February 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clarkson University</investigator_affiliation>
    <investigator_full_name>Ali Boolani</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plans to share individual participant data with other researchers</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 27, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/75/NCT03850275/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <pending_results>
    <submitted>January 22, 2020</submitted>
    <returned>January 30, 2020</returned>
    <submitted>February 17, 2020</submitted>
    <returned>February 27, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

